Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PURE Bioscience's change in inventory for the quarter that ended in Apr. 2026 was $0.01 Mil. It means PURE Bioscience's inventory
declined by $0.01 Mil
from Jan. 2026 to Apr. 2026 .
PURE Bioscience's change in inventory for the fiscal year that ended in Jul. 2025 was $-0.09 Mil. It means PURE Bioscience's inventory
increased by $0.09 Mil
from Jul. 2024 to Jul. 2025 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
PURE Bioscience's Days Inventory for the quarter that ended in Apr. 2026 was 91.64.
Inventory Turnover measures how fast the company turns over its inventory within a year.
PURE Bioscience's Inventory Turnover for the quarter that ended in Apr. 2026 was 1.00.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PURE Bioscience's Inventory-to-Revenue for the quarter that ended in Apr. 2026 was 0.47.
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PURE Bioscience's Inventory to Revenue for the quarter that ended in Apr. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PURE Bioscience Change In Inventory Related Terms
PURE Bioscience Change In Inventory Historical Data
* Premium members only.
The historical data trend for PURE Bioscience's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.10 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Inventory of $-0.10 Mil mean?
PURE Bioscience (PURE) has a Change In Inventory of $-0.10 Mil as of Apr. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for PURE Bioscience and its competitors.
Is PURE Bioscience's Change In Inventory too high?
PURE Bioscience's current Change In Inventory is $-0.10 Mil.
How does PURE Bioscience's Change In Inventory compare to DQWS and TANH?
PURE Bioscience's Change In Inventory of $-0.10 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Consumer Packaged Goods company?
A good Change In Inventory depends on the Consumer Packaged Goods industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for PURE Bioscience and its competitors. PURE Bioscience's current Change In Inventory is $-0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PURE Bioscience stock overvalued right now?
Based on GuruFocus' analysis, PURE Bioscience (PURE) is currently considered Possible Value Trap. The stock's GF Value™ is $0.10, compared to a current price of $0.06 — trading 36% below its estimated fair value. The current Change In Inventory is $-0.10 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For PURE Bioscience (PURE), the current Change In Inventory is $-0.10 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The company generates revenue from the sale of its antimicrobial products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PURE has been successfully added to your 
